BRIEF COMPANY PROFILE

The company is a well-established biotechnology organization founded in the late 2000s, built around a strong scientific focus on critical disorders and diseases. Over more than fifteen years, it has developed deep expertise in preclinical research and drug discovery, earning a solid reputation as a trusted partner within the global pharmaceutical and biotechnology industry. The organization has grown to several hundred employees and continues to expand rapidly, supported by sustained demand for its specialized capabilities.

The business operates through a dual model that combines external research services with internal innovation. On one side, it functions as a contract research organization, providing advanced research and development services to pharmaceutical and biotech companies. These services support partners across key stages of preclinical development. On the other side, the company maintains an internal discovery function, where it designs and develops its own drug candidates. These programs are advanced with the aim of forming strategic collaborations or licensing agreements with larger pharmaceutical partners, allowing the company to translate internal innovation into broader clinical and commercial impact.

The company’s specialization has enabled the organization to build a growing internal pipeline of therapeutic candidates while simultaneously delivering high-quality research services to external clients. The combination of a proprietary discovery platform and a clearly defined disease focus has positioned the company as a leader within its niche.

The company has achieved strong and consistent growth, reflected in a high compound annual revenue growth rate over recent years and a rapidly expanding workforce. It has collaborated with a large share of the world’s leading pharmaceutical companies, demonstrating broad industry reach and long-standing trust. As a publicly listed organization, it combines the agility of a science-driven biotech with the transparency and discipline of a mature corporate structure.

THE POSITION

POSITION PROFILE

• Leading end-to-end commercial evaluations for our client’s internal R&D pipeline and external opportunities, ensuring that market needs, scientific data, and value-creation potential are rigorously assessed and clearly communicated.
• Developing robust market analyses and business cases, including competitive landscapes, market sizing, unmet-need assessments, regulatory considerations, and partnership trends across relevant therapeutic areas.
• Driving quantitative and qualitative commercial assessments, such as sales forecasting, pricing assumptions, indication prioritization, and market share modelling to guide strategic decision-making and portfolio prioritization.
• Providing commercial leadership into licensing evaluations, including opportunity mapping, benchmarking, valuation, and due-diligence support for both in-licensing and out-licensing opportunities.
• Steering competitive commercial intelligence initiatives to support value proposition development, differentiation strategy, and positioning of early-stage assets in competitive markets.
• Continuously strengthening our client’s internal market knowledge systems, ensuring timely, relevant, and well-curated insights across therapeutic categories, competitors, and emerging technologies.
• Effectively communicating commercial insights, scenarios, and strategic recommendations to senior leadership and cross-functional teams, ensuring clarity around assumptions, risks, and opportunities.
• Managing workstreams, timelines, and analytical processes to deliver high-quality commercial evaluations within agreed business timelines.
• Supporting organizational capability building by fostering analytical excellence, cross-functional collaboration, and a strong commercial mindset across project teams.

• Delivering high-quality, data-driven commercial assessments that meaningfully support R&D portfolio decisions, indication prioritization, and licensing strategy.
• Ensuring internal pipeline assets are positioned clearly and competitively, supported by compelling value propositions and robust evidence of differentiation.
• Establishing a strong foundation of Competitive Commercial Intelligence, measured by timely insights, improved strategic readiness, and increased adoption by cross-functional stakeholders.
• Providing commercial leadership that contributes to successful in-licensing and out-licensing evaluations, including well-structured valuations, benchmarks, and business cases in collaboration with the with the Valuation Manager.
• Demonstrating excellence in forecasting, market modelling, and scenario analysis, ensuring alignment between commercial assumptions and scientific and clinical trajectories.
• Building robust market knowledge systems and intelligence processes, ensuring that our client remains informed of trends, competitors, partnerships, and shifts in the obesity, metabolic, and new flagship areas.
• Contributing to a high-performing, collaborative culture by supporting knowledge sharing, analytical best practices, and continuous improvement across teams.

CANDIDATE PROFILE

• Minimum 8 years of experience in pharmaceutical or biotech new product planning, commercial assessment, or strategy.
• Proven ability to position early-stage assets in competitive markets.
• In-depth experience in forecasting, market modeling, and valuation.
• Broad experience in synthesizing complex scientific and commercial data into clear strategic
• recommendations.